Three design decisions have the greatest impact on data quality and interpretability
But eating sweets and refined carbs can backfire when blood sugar spikes, insulin can overshoot the mark, causing a blood sugar crash
and Mayo, L.M., "GLP-1 receptor agonists for the treatment of alcohol use disorder," Journal of Clinical Investigation, May 1, 2025, doi: 10.1172/JCI192414 Hendershot, C.S., et al, "Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial," JAMA Psychiatry, April 1, 2025, doi: 10.1001/jamapsychiatry.2024.4789 Wang, W., et al, "Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes : Target Trial Emulation Using Real-World Data," Annals of Internal Medicine, Aug
Significant and Sustained Weight Loss Tirzepatide has demonstrated remarkable success in clinical trials, enabling patients to achieve significant weight loss, averaging 15 to 20 percent of their initial body weight